Stockreport

LENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024 [Yahoo! Finance]

LENZ Therapeutics, Inc.  (LENZ) 
PDF SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late clinical-stage biopharmaceutical company focused [Read more]